PHENOTYPIC ANALYSES OF LYMPHOKINE-ACTIVATED KILLER-CELLS THAT RELEASE INTERFERON-GAMMA AND TUMOR NECROSIS FACTOR-ALPHA

被引:12
作者
CHONG, ASF
YBARRONDO, B
GRIMES, WJ
HERSH, EM
SCUDERI, P
机构
[1] UNIV ARIZONA,DEPT INTERNAL MED,TUCSON,AZ 85721
[2] UNIV ARIZONA,DEPT MICROBIOL IMMUNOL,TUCSON,AZ 85721
[3] UNIV ARIZONA,DEPT BIOCHEM,TUCSON,AZ 85721
[4] RUSH PRESBYTERIAN ST LUKES MED CTR,DEPT IMMUNOL MICROBIOL,CHICAGO,IL 60612
关键词
D O I
10.1007/BF01789178
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We recently reported that interleukin-2(IL-2)-activated peripheral blood lymphocytes and CD3+, lymphokine-activated killer (LAK) cell clones release tumor necrosis factor α(TNFα) and interferon γ (IFNγ) when stimulated with K562 erythroleukemia cells. We examined the phenotype of IL-2-activated peripheral blood leukocytes that secrete TNFα and IFNγ when stimulated with K562 cells and demonstrated that TNFα secretion is not due to the presence of contaminating mononuclear phagocytes. Further, we demonstrate that IL-2-activated natural killer (NK) cells release only IFNγ when stimulated with K562 cells while T lymphocytes exposed to monoclonal anti-CD3 and K562 cells secrete both TNFα and IFNγ. However, T cells stimulated only with K562 cells did not release IFNγ or TNFα while the admixture of these T cells with NK cells, when stimulated with K562 cells, released levels of TNFα comparable to those produced by the unseparated cells. At present it is unclear whether only one or both effector cell types respond to K562 by releasing TNFα or why the presence both cell types is needed. © 1990 Springer-Verlag.
引用
收藏
页码:255 / 259
页数:5
相关论文
共 20 条
  • [1] CHONG ASF, 1989, J IMMUNOL, V142, P2133
  • [2] CHONG ASF, 1989, CANCER IMMUNOL IMMUN, V29, P270
  • [3] DEVITA VT, 1989, CANCER PRINCIPLES PR, V1, P301
  • [4] DJEU JY, 1988, J IMMUNOL, V141, P4047
  • [5] FIERS W, 1986, BIOL INTERFERON SYST, P205
  • [6] LACK OF CORRELATION BETWEEN PERIPHERAL-BLOOD LYMPHOKINE-ACTIVATED KILLER (LAK) CELL-FUNCTION AND CLINICAL-RESPONSE IN PATIENTS WITH ADVANCED MALIGNANT-MELANOMA RECEIVING RECOMBINANT INTERLEUKIN-2
    GHOSH, AK
    DAZZI, H
    THATCHER, N
    MOORE, M
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (03) : 410 - 414
  • [7] LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON - LYSIS OF NATURAL KILLER-RESISTANT FRESH SOLID TUMOR-CELLS BY INTERLEUKIN 2-ACTIVATED AUTOLOGOUS HUMAN PERIPHERAL-BLOOD LYMPHOCYTES
    GRIMM, EA
    MAZUMDER, A
    ZHANG, HZ
    ROSENBERG, SA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (06) : 1823 - 1841
  • [8] LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON .2. PRECURSOR PHENOTYPE IS SEROLOGICALLY DISTINCT FROM PERIPHERAL LYMPHOCYTES-T, MEMORY CYTO-TOXIC THYMUS-DERIVED LYMPHOCYTES, AND NATURAL-KILLER CELLS
    GRIMM, EA
    RAMSEY, KM
    MAZUMDER, A
    WILSON, DJ
    DJEU, JY
    ROSENBERG, SA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 157 (03) : 884 - 897
  • [9] HENKART PA, 1986, J IMMUNOL, V137, P2611
  • [10] JANICKE R, 1990, J IMMUNOL, V144, P1144